Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Research and development | 41M | 50M |
| Selling, general and administrative | 26M | 31M |
| Operating expenses | 67M | 81M |
| Net income | −59M | −71M |
| Earnings per share | −0.47 | −0.56 |
| Earnings per share, diluted | −0.47 | −0.56 |
| Weighted average shares | 126M | 125M |
| Weighted average shares, diluted | 126M | 125M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 15M | 12M | 24M | 34M | 33M | 28M | 5M | 26M |
| Current assets | 99M | 106M | 134M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −51M | −59M |
| Depreciation and amortisation | — | 2M |
| Share-based compensation | 7M | 13M |
| Capital expenditure | 1M | 2M |
| Investing cash flow | 35M | 66M |
| Financing cash flow | 214,000 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 151M |
| 142M |
| 133M |
| 144M |
| 171M |
| Property, plant and equipment | 4M | 3M | 4M | 4M | 4M | 4M | 4M | 5M |
| Total assets | 178M | 191M | 201M | 213M | 228M | 243M | 260M | 273M |
| Current liabilities | 8M | 8M | 9M | 8M | 8M | 8M | 9M | 9M |
| Total liabilities | 33M | 34M | 32M | 32M | 33M | 34M | 36M | 37M |
| Equity | 144M | 157M | 169M | 181M | 194M | 209M | 223M | 235M |
| Shares outstanding | 127M | 126M | 126M | 126M | 126M | 126M | 126M | 125M |
| Shares issued | 127M | 126M | 126M | 126M | 126M | 126M | 126M | 125M |
| 1M |